Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HECTOR S RODRIGUEZ

Allopathic & Osteopathic Physicians General Practice

NPI
1336172162
CMS profile
913452
Location
HIALEAH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$14.65

1 record · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $14.65 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Intercept Pharmaceuticals, Inc. $14.65 1

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HECTOR S RODRIGUEZ

NPI 1336172162 · CMS profile ID 913452

Allopathic & Osteopathic Physicians / General Practice

HIALEAH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336172162?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HECTOR S RODRIGUEZ, NPI 1336172162, CMS profile ID 913452. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336172162?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). HECTOR S RODRIGUEZ, NPI 1336172162, CMS profile ID 913452. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336172162?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
HECTOR S RODRIGUEZ, NPI 1336172162, CMS profile ID 913452, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–1 of 1 matching records. This page contains 1 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1336172162?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1 matching record · $14.65 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–1 of 1.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Intercept Pharmaceuticals, Inc. $14.6504/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113634496 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $400.00 1
PY2020 $24.41 1
PY2021 $107.09 6
PY2023 $23.30 1
PY2024 $14.65 1
PY2025 $12.30 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $25,394.92 10
PY2024 Principal investigator $29,811.50 8
PY2023 Principal investigator $76,568.72 70
PY2022 Principal investigator $243,103.73 84
PY2021 Principal investigator $201,728.87 84
PY2020 Principal investigator $47,402.66 42
PY2019 Principal investigator $16,120.45 36

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

70 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $1,904.14 12/22/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046025821
Principal investigator 1 Novo Nordisk AS $4,744.85 12/18/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007816087
Principal investigator 1 PFIZER INC. $11,726.70 12/13/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046098713
Principal investigator 1 PFIZER INC. $616.83 12/02/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1045969261
Principal investigator 1 PFIZER INC. $96.00 11/30/2023 Non-covered Recipient Entity
LIFE SPRING RESEARCH FOUNDATION LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046092107
Principal investigator 1 Novo Nordisk AS $6,829.92 11/27/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007816077
Principal investigator 1 Novo Nordisk AS $23.06 11/20/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296567
Principal investigator 1 Novo Nordisk AS $46.12 11/15/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296557
Principal investigator 1 Novo Nordisk AS $23.06 11/14/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296547
Principal investigator 1 PFIZER INC. $238.80 11/14/2023 Non-covered Recipient Entity
LIFE SPRING RESEARCH FOUNDATION LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1045937941
Principal investigator 1 PFIZER INC. $92.00 11/14/2023 Non-covered Recipient Entity
LIFE SPRING RESEARCH FOUNDATION LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1045987305
Principal investigator 1 PFIZER INC. $322.82 11/09/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046162197
Principal investigator 1 PFIZER INC. $845.95 10/31/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046143581
Principal investigator 1 Novo Nordisk AS $4,492.80 10/23/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007816065
Principal investigator 1 PFIZER INC. $10,183.24 10/20/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046079323
Principal investigator 1 Novo Nordisk AS $23.06 10/06/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296535
Principal investigator 1 Novo Nordisk AS $23.06 10/02/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296525
Principal investigator 1 PFIZER INC. $7,612.73 09/26/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046194533
Principal investigator 1 PFIZER INC. $80.00 09/09/2023 Non-covered Recipient Entity
Life Spring Research Fdn
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046006731
Principal investigator 1 PFIZER INC. $5,528.12 09/08/2023 Non-covered Recipient Entity
Life Spring Research Foundation LLC
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1045969247
Principal investigator 1 Novo Nordisk AS $23.06 09/07/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296515
Principal investigator 1 PFIZER INC. $403.92 08/28/2023 Non-covered Recipient Entity
Acevedo Clinical Research Associates
A PHASE 23 PROTOCOL TO INVESTIGATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED VACCINE CANDIDATES FOR SARSCOV2 NEW VARIANTS IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 1045874113
Principal investigator 1 Novo Nordisk AS $2,301.48 08/18/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296505
Principal investigator 1 PFIZER INC. $240.00 08/16/2023 Non-covered Recipient Entity
Life Spring Research Fdn
A PHASE 23 INTERVENTIONAL SAFETY PHARMACOKINETICS AND EFFICACY OPENLABEL MULTICENTER SINGLEARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332 NIRMATRELVIRRITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE No dispute reported 06/30/2026 1046273019
Principal investigator 1 Novo Nordisk AS $1,654.56 07/31/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296493
Principal investigator 1 PFIZER INC. $403.92 07/25/2023 Non-covered Recipient Entity
Acevedo Clinical Research Associates
A PHASE 23 PROTOCOL TO INVESTIGATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED VACCINE CANDIDATES FOR SARSCOV2 NEW VARIANTS IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 1045872747
Principal investigator 1 Novo Nordisk AS $9.99 06/30/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718233
Principal investigator 1 Novo Nordisk AS $240.13 06/30/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718249
Principal investigator 1 Novo Nordisk AS $23.06 06/29/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718219
Principal investigator 1 Novo Nordisk AS $23.06 06/27/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718197
Principal investigator 1 Novo Nordisk AS $2,298.24 06/23/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296483
Principal investigator 1 Novo Nordisk AS $2,806.92 05/26/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007296471
Principal investigator 1 Novo Nordisk AS $23.06 05/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718185
Principal investigator 1 Novo Nordisk AS $46.12 05/17/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718147
Principal investigator 1 Novo Nordisk AS $23.06 05/16/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718165
Principal investigator 1 Novo Nordisk AS $23.06 04/07/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007820713
Principal investigator 1 Novo Nordisk AS $23.06 04/03/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007820707
Principal investigator 1 Novo Nordisk AS $23.06 03/09/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718267
Principal investigator 1 PFIZER INC. $3,392.00 03/08/2023 Non-covered Recipient Entity
Acevedo Clinical Research Associates
A PHASE 12 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST VARICELLA ZOSTER VIRUS IN HEALTHY INDIVIDUALS No dispute reported 06/30/2026 1045959833
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718027
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718047
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718063
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718081
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718099
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718113
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1006718131
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007192683
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007209455
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007209469
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007209481
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007209495
Principal investigator 1 Novo Nordisk AS $2,660.04 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484839
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484849
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484859
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484869
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484879
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484893
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007820687
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007820693
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007820701
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008280073
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295237
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295251
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295265
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295283
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295297
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295311
Principal investigator 1 Novo Nordisk AS $30.00 02/22/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295325
Principal investigator 1 Novo Nordisk AS $99.90 01/30/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1008295221
Principal investigator 1 Novo Nordisk AS $3,533.76 01/25/2023 Non-covered Recipient Entity
LIFESPRING RESEARCH FOUNDATION
NN9535-4321 No dispute reported 06/30/2026 1007484829